Page last updated: 2024-09-05

sb 203580 and Uremia

sb 203580 has been researched along with Uremia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Peng, KF; Sun, Y; Wu, XF; Zhao, HW	1

Other Studies

1 other study(ies) available for sb 203580 and Uremia

Article	Year
Advanced oxidation protein products induce monocyte chemoattractant protein-1 expression via p38 mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Chinese medical journal, 2006, Jul-05, Volume: 119, Issue:13 Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Cells, Cultured; Chemokine CCL2; Enzyme Activation; Imidazoles; Kidney Failure, Chronic; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Proteins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uremia	2006

Article

Year

Advanced oxidation protein products induce monocyte chemoattractant protein-1 expression via p38 mitogen-activated protein kinase activation in rat vascular smooth muscle cells.

Chinese medical journal, 2006, Jul-05, Volume: 119, Issue:13

Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Cells, Cultured; Chemokine CCL2; Enzyme Activation; Imidazoles; Kidney Failure, Chronic; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Proteins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uremia

2006